4-butyrolactone has been researched along with Absence Status in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lian, XY; Stringer, JL; Xu, K | 1 |
| Ferris, CF; King, JA; Marshall, PC; Tenney, JR | 1 |
2 other study(ies) available for 4-butyrolactone and Absence Status
| Article | Year |
|---|---|
Oral administration of fructose-1,6-diphosphate has anticonvulsant activity.
Topics: 4-Butyrolactone; Action Potentials; Administration, Oral; Animals; Anticonvulsants; Brain; Cerebral Cortex; Convulsants; Disease Models, Animal; Epilepsy; Fructosediphosphates; Male; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Treatment Outcome | 2008 |
fMRI of generalized absence status epilepticus in conscious marmoset monkeys reveals corticothalamic activation.
Topics: 4-Butyrolactone; Animals; Brain; Callithrix; Cerebral Cortex; Consciousness; Disease Models, Animal; Epilepsy, Absence; Magnetic Resonance Imaging; Male; Neural Pathways; Oxygen; Status Epilepticus; Thalamus | 2004 |